Safer catheterisation. Smarter drainage. Dignity restored.
Gomida builds a connected urology product family around amSafeX, amSmart, SupraSense and BiPS — solving pain, preventable injury and long-term care gaps with protected device innovation.
Four products. One urology channel.
Each product is positioned for the same clinical ecosystem: urologists, hospitals, long-term care and distributors.
amSafeX Urethra-Safe Catheter
Engineered confirmation before balloon inflation, aiming to eliminate preventable urethral injury.
amSmart UroWear Bag
Discreet wearable urine bag with smart monitoring, patient alerts and dignity-focused drainage.
SupraSense Suprapubic Platform
Pressure sensing and drainage intelligence for suprapubic and long-term bladder care.
BiPS Biodegradable Prostate Stent
A biodegradable stenting concept for BPH relief without a repeat removal procedure.
Leadership team
Engineers, clinicians and global advisors with deep medical-device, urology, regulatory and commercialization experience.
Sunil Kumar Singh
Founder & CEO · B.Tech Electronics · 20+ yrs · ex-Stryker, ZF
Prof. Dr. Anil Mandhani
Co-Founder & CTO, Urology · MBBS, MS, MCh · 30+ yrs · Chairman Urology, Fortis
Sara Al hassnaoui
Marketing · Executive Business Administration · M2 Healthcare Business
Rupinder Singh
President, Sales · Gold Medallist Biotech · 25+ yrs BD
Ajit Manocha
Mentor & Advisor · CEO/President SEMI Global · ex-CEO GlobalFoundries
Venkat Bhagavati
VP Regulatory Affairs · MS Bioengineering
Patents & clinical evidence
A central public area for granted patents, patent applications, peer-reviewed evidence and planned clinical-validation spaces.
amSafeX
India Patent 587173 granted. CDSCO approved and selling in India. Clinical study: zero urethral injuries in 125 patients, published in Urology Video Journal 27 (2025).
Open evidenceamSmart
US Patent 12,419,777 B2 granted. India Patent 535002 granted. Clinical evidence and connected-care validation space included.
Open evidenceSupraSense
Patent application under process. Evidence space for suprapubic population, bladder-pressure monitoring and validation studies.
Open evidenceBiPS
Patent application under process. Material development at IIT Roorkee and clinical-evaluation planning highlighted.
Open evidence